Last updated 2026-10-28
- Raised $7.3M PIPE, Oct 2009
- Raised $4.4M PIPE, May 2009
- Raised $2M PIPE led by Wheddon Ltd., May 2007
Total raised
$13.7M
Stage
Public
Founded
2005
Headcount
2
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
Hadasit Bio-Holdings Ltd. (HBL) is a publicly traded subsidiary of Hadasit Ltd., the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. HBL was established to promote and commercialize intellectual property and R&D capabilities generated by Hadassah, focusing on funding the preparation and execution of Phase I and Phase II clinical trials for its portfolio companies. It provides investment exposure to a select cluster of biotech companies based on inventions developed and owned by Hadassah University Hospital.
Funding history · 3 rounds · $13.7M total
3 events/rounds · $13.7M Total Funding: $13.7M in Private Equity
Oct 2009
PIPE
$7.3M
May 2009
PIPE
$4.4M
May 2007
PIPE
$2.0M
★ Wheddon Ltd.
Offices
Jerusalem, Israel · HQ / main office
Q&A
- What is HBL-Hadasit Bio Holdings?
- HBL-Hadasit Bio Holdings is a publicly traded holding company that invests in early-stage Israeli biotech companies, primarily those originating from Hadassah University Hospital.
- When was HBL-Hadasit Bio Holdings founded?
- HBL-Hadasit Bio Holdings was founded in September 2005.
- What is the primary focus of HBL-Hadasit Bio Holdings' investments?
- HBL-Hadasit Bio Holdings focuses on funding the preparation and execution of Phase I and Phase II clinical trials for its portfolio companies, which are based on inventions developed and owned by Hadassah University Hospital.
- How much capital has HBL-Hadasit Bio Holdings raised in total?
- HBL-Hadasit Bio Holdings has raised a total of $13.74 million USD.
- What was HBL-Hadasit Bio Holdings' most recent funding round?
- HBL-Hadasit Bio Holdings completed a PIPE funding round in October 2009, raising $7.34 million USD.
- Which company did HBL-Hadasit Bio Holdings invest in during January 2012?
- In January 2012, HBL-Hadasit Bio Holdings invested $1.4 million USD in Thrombotech Ltd.
- Who is the CEO of HBL-Hadasit Bio Holdings?
- Miryam Valensi Tobaly serves as the CEO of HBL-Hadasit Bio Holdings.
- What is the employee count for HBL-Hadasit Bio Holdings?
- HBL-Hadasit Bio Holdings has 1-10 employees.
Team · 1
Miryam Valensi Tobaly
CEO
Tags
biotechnologymedical-researchlife-scienceshealthcareinvestment-company
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | www.hbl.co.il |
|---|
Identifiers & details
| Legal name | Hadasit Bio-Holdings Ltd. |
|---|---|
| Founded | 2005-9 |
| Employees (exact) | 2 |